ES2157107T3 - Uso de moxonidina para el tratamiento del dolor neuropatico. - Google Patents

Uso de moxonidina para el tratamiento del dolor neuropatico.

Info

Publication number
ES2157107T3
ES2157107T3 ES98117344T ES98117344T ES2157107T3 ES 2157107 T3 ES2157107 T3 ES 2157107T3 ES 98117344 T ES98117344 T ES 98117344T ES 98117344 T ES98117344 T ES 98117344T ES 2157107 T3 ES2157107 T3 ES 2157107T3
Authority
ES
Spain
Prior art keywords
moxonidine
treatment
neuropathic pain
composition
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98117344T
Other languages
English (en)
Inventor
Carolyn A Fairbanks
George L Wilcox
Tinna M Laughlin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Products GmbH
Original Assignee
Solvay Pharmaceuticals GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals GmbH filed Critical Solvay Pharmaceuticals GmbH
Application granted granted Critical
Publication of ES2157107T3 publication Critical patent/ES2157107T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UN PROCEDIMIENTO PARA ALIVIAR EL DOLOR NEUROPATICO UTILIZA MOXONIDINA Y SUS SALES ACIDAS DE ADICION FISIOLOGICAMENTE COMPATIBLES PARA EL TRATAMIENTO Y/O LA PROFILAXIS DEL DOLOR NEUROPATICO. A UN SUJETO QUE NECESITE DICHO TRATAMIENTO, SE LE ADMINISTRA UNA COMPOSICION QUE COMPRENDE UNA CANTIDAD EFECTIVA DE MOXONIDINA Y UNA SAL FARMACEUTICAMENTE ACEPTABLE DE LA MISMA, EN UN VEHICULO FARMACEUTICAMENTE ACEPTABLE. LA COMPOSICION PUEDE ADMINISTRARSE INTRATECALMENTE.
ES98117344T 1997-09-16 1998-09-14 Uso de moxonidina para el tratamiento del dolor neuropatico. Expired - Lifetime ES2157107T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5902197P 1997-09-16 1997-09-16

Publications (1)

Publication Number Publication Date
ES2157107T3 true ES2157107T3 (es) 2001-08-01

Family

ID=22020310

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98117344T Expired - Lifetime ES2157107T3 (es) 1997-09-16 1998-09-14 Uso de moxonidina para el tratamiento del dolor neuropatico.

Country Status (8)

Country Link
US (1) US6054461A (es)
EP (1) EP0901790B1 (es)
AT (1) ATE201598T1 (es)
DE (1) DE69800859T2 (es)
DK (1) DK0901790T3 (es)
ES (1) ES2157107T3 (es)
GR (1) GR3036071T3 (es)
PT (1) PT901790E (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6559186B1 (en) 1990-02-26 2003-05-06 Arc 1, Inc. Compositions and methods of treatment of sympathetically maintained pain
DE19911371A1 (de) * 1999-03-15 2000-09-21 Solvay Pharm Gmbh Arzneimittel zur Behandlung von funktionellen Störungen und Erkrankungen der unteren Darmwege, insbesondere von damit einhergehenden abdominalen visceralen Schmerzen
US7015371B2 (en) * 2001-03-07 2006-03-21 Mary Hannaman Romans Non-traumatic model for neurogenic pain
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
EP1517688A2 (de) * 2002-06-19 2005-03-30 Solvay Pharmaceuticals GmbH Arzneimittel zur behandlung von eine inhibition oder aktivitätsverminderung von ph-wert-regulierenden bikarbonat-transporter-proteinen erfordernden erkrangungen
BRPI0406749A (pt) * 2003-01-13 2005-12-20 Dynogen Pharmaceuticals Inc Métodos relacionados ao tratamento de distúrbios fincionais do intestino e composição farmacêutica
AU2004204827B2 (en) * 2003-01-13 2006-06-29 Dynogen Pharmaceuticals, Inc. Method of treating nausea, vomiting, retching or any combination thereof
WO2004071421A2 (en) * 2003-02-05 2004-08-26 Teva Pharmaceutical Industries Ltd. Sustained release formulation of n-(2-propylpentanoyl) glycinamide and related compounds
WO2004071424A2 (en) * 2003-02-05 2004-08-26 Teva Pharmaceutical Industries, Ltd. Immediate release formulation of n-(2-propylpentanoyl)glycinamide
AU2004229551A1 (en) * 2003-04-14 2004-10-28 Pain Therapeutics, Inc. Methods for the treatment of pain comprising opioid antagonists
WO2006105117A2 (en) * 2005-03-28 2006-10-05 Dynogen Pharmaceuticals, Inc. Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
ATE493128T1 (de) * 2005-11-08 2011-01-15 Arcion Therapeutics Inc Behandlung von längenabhängiger neuropathie
US8026266B2 (en) * 2005-11-08 2011-09-27 Arcion Therapeutics, Inc. Treatment of length dependent neuropathy
US7964585B2 (en) * 2006-03-14 2011-06-21 Case Western Reserve University Composition and method of treating peripheral neuropathy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2104873C (en) * 1991-02-26 2000-05-23 James N. Campbell Compositions and methods of treatment of sympathetically maintained pain

Also Published As

Publication number Publication date
DE69800859T2 (de) 2001-09-27
DE69800859D1 (de) 2001-07-05
GR3036071T3 (en) 2001-09-28
US6054461A (en) 2000-04-25
PT901790E (pt) 2001-09-28
ATE201598T1 (de) 2001-06-15
DK0901790T3 (da) 2001-08-06
EP0901790B1 (en) 2001-05-30
EP0901790A1 (en) 1999-03-17

Similar Documents

Publication Publication Date Title
MY119403A (en) Novel compounds with analgesic effect.
BR9913932A (pt) Uso de análogos de glp-1 no tratamento de derrame
ES2156839T1 (es) Medicamento que contiene alginato e implante para tratar la fibrosis.
MY132705A (en) Novel compounds with analgesic effect
NZ241873A (en) Film-coated solid dosage formulation comprising 3-[2-(dimethylamino)ethyl]-n-methyl-1h-indole-5-methanesulphonamide
DK0901790T3 (da) Anvendelse af moxonidin til behandling af neuropatisk smerte
IL108284A0 (en) Use of riluzole for the treatment of parkinson's disease and parkinsonian syndromes
BR9711447A (pt) Uso de glp-1 an logos no tratamento de enfarte de mioc rdio
MY115662A (en) Novel compounds with analgesic effect
PT777482E (pt) Composicao de combinacao para utilizacao em doencas imunologicas
ITMI922331A1 (it) Uso di paratormone, suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione
ID24184A (id) Obat untuk perawatan disfungsi ereksi
DE69835461D1 (de) Anti-arrhythmische Zusammensetzungen und Behandlungsverfahren
DE3875611D1 (de) Pharmazeutische zusammensetzungen.
ES2162813T3 (es) Uso de 3,5-diamino-6-(2,3-diclorofenil)-1,2,4-triazina en la preparacion de un farmaco para el tratamiento de ciertos tipos de dolor y edema.
ES2157984T3 (es) Utilizacion de 4'-yodo-4'-desoxidoxorrubicina para el tratamiento de la amidoidosis.
ES2139774T3 (es) Uso de una combinacion de antineoplastones en la preparacion de un medicamento para el tratamiento de la neurofibromatosis.
CO5031290A1 (es) Formulacion lo
ES2147796T3 (es) Composicion para el tratamiento o la prevencion del herpes.
ES2086536T3 (es) Uso de ketorolaco para el tratamiento de la enfermedad periodontal.
NZ508292A (en) Treatment of migraine symptoms with ibuprofen and salts thereof
ES2062752T3 (es) Preparado de una sal de oxipurinol en forma oral para el tratamiento de hiperuricemia.
ZA9427B (en) Use of riluzole for promoting restoration following radiation
AR013424A1 (es) Uso de uridina para la preparacion de una composicion farmaceutica util para inhibir la toxicidad de los analogos de pirimidina
CA2198217A1 (en) Use of selegiline to prolong life span

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 901790

Country of ref document: ES